• entrada therapeutics, inc. (trda) investigation: bronstein, gewir The National Law Review Fri, 03 Jul 2026 18:07:54 GMT
• entrada therapeutics, inc.(nasdaqgm: trda) dropped from russell 2000 defensive index marketscreener.com Mon, 29 Jun 2026 21:21:18 GMT
• price to book forward of entrada therapeutics, inc. – nasdaq:trda TradingView Fri, 26 Jun 2026 20:19:47 GMT
• price to earnings forward of entrada therapeutics, inc. – nasdaq:trda TradingView Fri, 26 Jun 2026 20:05:22 GMT
• entrada therapeutics inc actuals & estimates (nasdaq:trda) TradingView Fri, 26 Jun 2026 03:55:25 GMT
• entrada therapeutics inc (trda) earnings forecast: future eps & revenue growth estimates TradingKey Mon, 22 Jun 2026 07:00:00 GMT
• entrada therapeutics inc (trda) technical analysis: support, resistance, indicators & moving averages TradingKey Mon, 22 Jun 2026 07:00:00 GMT
• entrada therapeutics inc (trda) shareholder structure: major shareholders & institutional holdings TradingKey Thu, 18 Jun 2026 10:53:31 GMT
• Entrada Therapeutics Inc (TRDA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution TradingKey Thu, 18 Jun 2026 10:51:28 GMT
• entrada therapeutics inc (trda) dividends & stock splits: historical payouts and event timeline TradingKey Thu, 18 Jun 2026 10:20:09 GMT
• Avoiding Lag: Real-Time Signals in (TRDA) Movement Stock Traders Daily Thu, 18 Jun 2026 07:28:02 GMT
• entrada therapeutics inc (trda) earnings forecast: future eps & revenue growth estimates TradingKey Wed, 17 Jun 2026 18:32:55 GMT
• entrada therapeutics inc (trda) risk assessment: volatility, financial risk & investment risk TradingKey Wed, 17 Jun 2026 17:53:09 GMT
• entrada therapeutics inc (trda) financial health: profitability & balance sheet analysis TradingKey Wed, 17 Jun 2026 17:52:00 GMT
• entrada therapeutics inc (trda) valuation: pe, pb & fair value analysis TradingKey Wed, 17 Jun 2026 17:50:29 GMT
• entrada therapeutics inc (trda) technical analysis: support, resistance, indicators & moving averages TradingKey Wed, 17 Jun 2026 17:48:02 GMT
• entrada therapeutics inc (trda) financial health: profitability & balance sheet analysis TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• entrada therapeutics inc (trda) technical analysis: support, resistance, indicators & moving averages TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• entrada therapeutics inc (trda) valuation: pe, pb & fair value analysis TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• entrada therapeutics inc (trda) risk assessment: volatility, financial risk & investment risk TradingKey Tue, 16 Jun 2026 07:00:00 GMT
• entrada therapeutics (trda) awards director 19,000 options at $5.97 Stock Titan Fri, 12 Jun 2026 21:16:38 GMT
• [Form 4] Entrada Therapeutics, Inc. Insider Trading Activity Stock Titan Fri, 12 Jun 2026 07:00:00 GMT
• entrada therapeutics director granted 19,000 options | trda insider trading Stock Titan Fri, 12 Jun 2026 07:00:00 GMT
• entrada therapeutics (trda) director receives 19,000-share stock option grant Stock Titan Fri, 12 Jun 2026 07:00:00 GMT
• entrada therapeutics (trda) director receives grant of 19,000 stock options Stock Titan Fri, 12 Jun 2026 07:00:00 GMT
• entrada therapeutics (trda) gains ground: modest rally tests key resistance levels - rsi oversold picks newsline.com Thu, 11 Jun 2026 14:31:21 GMT
• entrada therapeutics stockholders approve directors and equity plans The Globe and Mail Thu, 11 Jun 2026 07:00:00 GMT
• entrada therapeutics stockholders approve directors and equity plans TipRanks Wed, 10 Jun 2026 20:59:41 GMT
• entrada therapeutics (trda) shareholders approve plan changes and re-elect directors Stock Titan Wed, 10 Jun 2026 07:00:00 GMT
• Analysts Have Conflicting Sentiments on These Healthcare Companies: Entrada Therapeutics Inc (TRDA) and Pfizer (PFE) The Globe and Mail Tue, 09 Jun 2026 07:00:00 GMT
• entrada therapeutics inc. (trda) q1 2026 earnings: narrower loss surprises, but no revenue weighs on shares - roic trend report newsline.com Mon, 08 Jun 2026 18:48:05 GMT
• entrada therapeutics (trda) goldman sachs 47th annual global healthcare conference 2026 summary Quartr Mon, 08 Jun 2026 13:09:19 GMT
• Entrada Therapeutics Inc. (TRDA) Faces Selling Pressure as Shares Dip to $6.20 - Triple Top dars.gov.et Mon, 08 Jun 2026 07:00:00 GMT
• entrada therapeutics price target lowered to $17 from $20 at guggenheim TipRanks Mon, 08 Jun 2026 07:00:00 GMT
• discipline and rules-based execution in trda response Stock Traders Daily Sun, 07 Jun 2026 05:58:02 GMT
• INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Entrada Therapeutics, Inc. - TRDA PR Newswire Thu, 04 Jun 2026 07:00:00 GMT
• oppenheimer remains a buy on entrada therapeutics inc (trda) The Globe and Mail Thu, 04 Jun 2026 07:00:00 GMT
• trda: strong safety and early efficacy in dmd trials drive confidence in a growing clinical pipeline TradingView Wed, 03 Jun 2026 22:42:15 GMT
• oppenheimer maintains entrada therapeutics(trda.us) with buy rating, maintains target price $23 Moomoo Wed, 03 Jun 2026 07:00:00 GMT
• entrada therapeutics advances elevate-45-201 clinical study to 10 mg/kg dosage cohort geneonline.com Wed, 03 Jun 2026 03:58:54 GMT
• independent safety data monitoring committee recommends initiation of cohort 2 at the increased dose of 10 mg/kg in entrada therap... The Manila Times Tue, 02 Jun 2026 11:21:09 GMT
• rare disease trial tests dmd treatment with once-every-six-week dosing Stock Titan Tue, 02 Jun 2026 07:00:00 GMT
• entrada therapeutics announces inducement grants under nasdaq listing rule 5635(c)(4) The Manila Times Tue, 02 Jun 2026 07:00:00 GMT
• safety committee approves higher 10 mg/kg dose for entrada's duchenne muscular dystrophy trial Pluang Tue, 02 Jun 2026 07:00:00 GMT
• law firm probes entrada therapeutics for possible securities fraud after weak drug trial data. Pluang Tue, 02 Jun 2026 07:00:00 GMT
• entrada therapeutics announces inducement grants under nasdaq listing rule 5635(c)(4) Yahoo Finance Mon, 01 Jun 2026 07:00:00 GMT
• entrada therapeutics faces investigation after drug trial data disappoints, stock plunges 57%. Pluang Fri, 29 May 2026 01:08:56 GMT
• investor alert: pomerantz law firm investigates claims on behalf of investors of entrada therapeutics, inc. - trda PR Newswire Thu, 28 May 2026 07:00:00 GMT
• bronstein, gewirtz & grossman, llc initiates an investigation into allegations against entrada therapeutics, inc. (trda) and encou... ACCESS Newswire Wed, 27 May 2026 16:41:22 GMT
• 2026-05-27 | bronstein, gewirtz & grossman, llc initiates an investigation into allegations against entrada therapeutics, inc. (tr... Stockhouse Wed, 27 May 2026 15:00:00 GMT
• behavioral patterns of trda and institutional flows Stock Traders Daily Wed, 27 May 2026 07:00:00 GMT
• duchenne muscular dystrophy clinical trial pipeline: delveinsight highlights major advances, transformative therapies, and 75+ lea... The Manila Times Tue, 26 May 2026 17:11:48 GMT
• bronstein, gewirtz & grossman, llc announces an investigation against entrada therapeutics, inc. (trda) and encourages shareholder... ACCESS Newswire Tue, 26 May 2026 16:48:09 GMT
• entrada therapeutics, inc. (trda) investigation: bronstein, gewirtz & grossman, llc encourages investors to contact the firm to le... ACCESS Newswire Tue, 26 May 2026 13:48:47 GMT
• entrada plunges after early-stage trial data for duchenne therapy MSN Mon, 25 May 2026 13:09:00 GMT
• bronstein, gewirtz & grossman, llc encourages entrada therapeutics, inc. (trda) shareholders to inquire about securities investiga... ACCESS Newswire Mon, 25 May 2026 11:40:19 GMT
• entrada therapeutics, inc. (trda) investigation: bronstein, gewirtz & grossman, llc encourages shareholders to contact the firm to... ACCESS Newswire Sat, 23 May 2026 01:15:00 GMT
• entrada therapeutics director bernhardt zeiher buys $29,316 in stock by investing.com Investing.com India Fri, 22 May 2026 07:00:00 GMT
• entrada plunges after early-stage trial data for duchenne therapy MSN Fri, 22 May 2026 02:19:52 GMT
• bronstein, gewirtz & grossman, llc is investigating entrada therapeutics, inc. (trda) and encourages investors to connect ACCESS Newswire Fri, 22 May 2026 01:27:40 GMT
• bronstein, gewirtz & grossman, llc is investigating entrada thera The National Law Review Thu, 21 May 2026 21:56:07 GMT
• entrada therapeutics director bernhardt zeiher buys $29,316 in stock by investing.com Investing.com Nigeria Thu, 21 May 2026 07:00:00 GMT
• entrada therapeutics (trda) director’s trust buys 5,000 common shares Stock Titan Thu, 21 May 2026 07:00:00 GMT
• bronstein, gewirtz & grossman, llc encourages entrada therapeutic The National Law Review Wed, 20 May 2026 20:48:28 GMT
• entrada plunges after early-stage trial data for duchenne therapy MSN Wed, 20 May 2026 15:13:31 GMT
• bronstein, gewirtz & grossman, llc announces an investigation against entrada therapeutics, inc. (trda) and encourages investors t... ACCESS Newswire Tue, 19 May 2026 23:18:01 GMT
• entrada therapeutics reports positive phase 1/2 results for entr-601-44 in duchenne muscular dystrophy, highlighting best-in-class... Minichart Tue, 19 May 2026 18:06:00 GMT
• entrada therapeutics highlights transformational year and pipeline progress TipRanks Tue, 19 May 2026 10:52:52 GMT
• Entrada Therapeutics updates corporate presentation, cites DMD Cohort 1 safety and functional gains; Cohort 2/45 data due 2026 TradingView Tue, 19 May 2026 07:00:00 GMT
• entrada plunges after early-stage trial data for duchenne therapy MSN Tue, 19 May 2026 05:25:41 GMT
• entrada therapeutics, inc. (trda) investigation: bronstein, gewir The National Law Review Mon, 18 May 2026 19:51:21 GMT
• INVESTOR ALERT: Investigation of Entrada Therapeutics, Inc. (TRDA) announced by Holzer & Holzer, LLC GlobeNewswire Mon, 18 May 2026 07:00:00 GMT
• entrada therapeutics (trda) furnishes updated corporate presentation to investors Stock Titan Mon, 18 May 2026 07:00:00 GMT
• trda investors have opportunity to join entrada therapeutics, inc. fraud investigation with the schall law firm Scott Coop Mon, 18 May 2026 05:38:29 GMT
• entrada therapeutics dmd trial shows early functional gains, clean safety profile MSN Mon, 18 May 2026 01:19:30 GMT
• Entrada Therapeutics, Inc. (TRDA) Investigation: Bronstein, Gewir The National Law Review Sun, 17 May 2026 22:53:34 GMT
• entrada plunges after early-stage trial data for duchenne therapy MSN Sun, 17 May 2026 13:56:43 GMT
• entrada therapeutics clinical trial data sparks brutal stock selloff - here's why MSN Sun, 17 May 2026 09:25:42 GMT
• TRDA Investors Have Opportunity to Join Entrada Therapeutics, Inc. Fraud Investigation with the Schall Law Firm GlobeNewswire Sun, 17 May 2026 07:00:00 GMT
• (trda) movement within algorithmic entry frameworks Stock Traders Daily Sat, 16 May 2026 07:00:00 GMT
• entrada plunges after early-stage trial data for duchenne therapy MSN Fri, 15 May 2026 23:14:59 GMT
• bronstein, gewirtz & grossman, llc announces an investigation against entrada therapeutics, inc. (trda) and encourages stockholder... ACCESS Newswire Fri, 15 May 2026 19:50:37 GMT
• entrada therapeutics, inc. (trda) investigation: bronstein, gewir The National Law Review Fri, 15 May 2026 07:00:00 GMT
• entrada therapeutics faces investigation after drug trial results disappoint, stock plunges 57%. Pluang Fri, 15 May 2026 05:16:40 GMT
• investor alert: pomerantz law firm investigates claims on behalf of investors of entrada therapeutics, inc. - trda PR Newswire Fri, 15 May 2026 02:30:00 GMT
• bronstein, gewirtz & grossman, llc encourages entrada therapeutic The National Law Review Thu, 14 May 2026 18:12:00 GMT
• entrada therapeutics dmd trial shows early functional gains, clean safety profile MSN Thu, 14 May 2026 12:23:21 GMT
• entrada therapeutics, inc. common stock (trda) stock price today & analysis Gotrade Thu, 14 May 2026 12:10:39 GMT
• investor alert: pomerantz law firm investigates claims on behalf of investors of entrada therapeutics, inc. - trda PR Newswire Thu, 14 May 2026 07:00:00 GMT
• entrada therapeutics faces investigation after drug trial results disappoint, stock plunges 57%. Pluang Thu, 14 May 2026 07:00:00 GMT
• entrada plunges after early-stage trial data for duchenne therapy MSN Thu, 14 May 2026 05:08:09 GMT
• bronstein, gewirtz & grossman, llc initiates an investigation int The National Law Review Wed, 13 May 2026 18:08:15 GMT
• entrada plunges after early-stage trial data for duchenne therapy MSN Wed, 13 May 2026 16:45:57 GMT
• entrada plunges after early-stage trial data for duchenne therapy MSN Tue, 12 May 2026 00:13:36 GMT
• roth mkm maintains entrada therapeutics(trda.us) with buy rating, maintains target price $10 Moomoo Mon, 11 May 2026 13:35:01 GMT
• Entrada Therapeutics, Inc. Shareholders Are Encouraged to GlobeNewswire Mon, 11 May 2026 07:00:00 GMT
• how entrada therapeutics (trda) handles its debt maturity schedule | q1 2026: eps beats forecasts - post-earnings reaction newsline.com Mon, 11 May 2026 07:00:00 GMT
• investors in entrada therapeutics urged to join probe after stock drops on clinical trial results Pluang Mon, 11 May 2026 07:00:00 GMT
• entrada therapeutics (trda) stock price, news & analysis $trda MarketBeat Mon, 11 May 2026 07:00:00 GMT
• entrada plunges after early-stage trial data for duchenne therapy MSN Sun, 10 May 2026 14:51:34 GMT
• entrada plunges after early-stage trial data for duchenne therapy MSN Sat, 09 May 2026 09:19:59 GMT
• entrada therapeutics dmd trial shows early functional gains, clean safety profile Yahoo Finance Sat, 09 May 2026 07:00:00 GMT
• analysts offer insights on healthcare companies: gilead sciences (gild), entrada therapeutics inc (trda) and contineum therapeutic... The Globe and Mail Sat, 09 May 2026 07:00:00 GMT
• transcript : entrada therapeutics, inc., q1 2026 earnings call, may 07, 2026 marketscreener.com Sat, 09 May 2026 07:00:00 GMT
• entrada therapeutics, inc. - common stock (nq: trda FinancialContent Fri, 08 May 2026 20:15:00 GMT
• td cowen maintains entrada therapeutics(trda.us) with buy rating 富途牛牛 Fri, 08 May 2026 12:59:34 GMT
• entrada therapeutics cut to neutral from buy by hc wainwright & co. Moomoo Fri, 08 May 2026 12:08:00 GMT
• entrada therapeutics downgraded to neutral from buy at h.c. wainwright TipRanks Fri, 08 May 2026 11:31:09 GMT
• Entrada Therapeutics (TRDA) Q1 Revenue Slump Tests High Growth Narratives simplywall.st Fri, 08 May 2026 07:00:00 GMT
• Entrada’s stock drops as DMD drug’s efficacy falls short Clinical Trials Arena Fri, 08 May 2026 07:00:00 GMT
• entrada therapeutics dmd trial shows early functional gains, clean safety profile Yahoo Finance Fri, 08 May 2026 07:00:00 GMT
• h.c. wainwright downgrades entrada therapeutics(trda.us) to hold rating Moomoo Fri, 08 May 2026 07:00:00 GMT
• roth mkm maintains entrada therapeutics(trda.us) with buy rating, cuts target price to $10 Moomoo Fri, 08 May 2026 07:00:00 GMT
• this hubspot analyst turns bearish; here are top 5 downgrades for friday Sahm Fri, 08 May 2026 07:00:00 GMT
• analysts offer insights on healthcare companies: entrada therapeutics inc (trda) and beam therapeutics (beam) The Globe and Mail Fri, 08 May 2026 07:00:00 GMT
• entrada therapeutics price target lowered to $10 from $19 at roth capital TipRanks Fri, 08 May 2026 07:00:00 GMT
• entrada therapeutics (trda) earnings date and reports 2026 $trda MarketBeat Fri, 08 May 2026 07:00:00 GMT
• entrada plunges after early-stage trial data for duchenne therapy MSN Fri, 08 May 2026 06:59:08 GMT
• entrada therapeutics clinical trial data sparks brutal stock selloff - here's why MSN Fri, 08 May 2026 05:16:01 GMT
• entrada therapeutics declines on duchenne muscular dystrophy study data -- update Moomoo Fri, 08 May 2026 02:20:31 GMT
• entrada emphasises dmd therapy's safety as dystrophin data disappoint FirstWord Pharma Fri, 08 May 2026 00:25:34 GMT
• entrada therapeutics declines on duchenne muscular dystrophy study data -- update Moomoo Thu, 07 May 2026 23:20:00 GMT
• entrada plunges after early-stage trial data for duchenne therapy MSN Thu, 07 May 2026 22:50:22 GMT
• entrada therapeutics reports topline data from cohort 1 of elevate-44-201 study TipRanks Thu, 07 May 2026 19:17:50 GMT
• entrada therapeutics (nasdaq:trda) plunges nearly 48% as early-stage dmd clinical data disappoints on drug exposure ChartMill Thu, 07 May 2026 13:14:54 GMT
• entrada therapeutics reports q1 eps (95c), consensus ($1.02) TipRanks Thu, 07 May 2026 13:10:44 GMT
• press release: entrada therapeutics reports first quarter 2026 financial results Moomoo Thu, 07 May 2026 11:10:00 GMT
• entrada's duchenne drug shown to improve muscle function in early trial marketscreener.com Thu, 07 May 2026 11:06:33 GMT
• Entrada crashes as Duchenne therapy comes in ‘below expectations’ in early study BioSpace Thu, 07 May 2026 07:00:00 GMT
• Entrada's stock craters as DMD data underperform expectations, handing advantage to Novartis Fierce Biotech Thu, 07 May 2026 07:00:00 GMT
• Entrada Reports Early Functional Benefit in Phase 1/2 Duchenne Study of ENTR-601-44 BioPharm International Thu, 07 May 2026 07:00:00 GMT
• Entrada Therapeutics Reports Positive Topline Results from ELEVATE-44-201 Study in Duchenne Muscular Dystrophy and Updates on Clin... Quiver Quantitative Thu, 07 May 2026 07:00:00 GMT
Entrada Therapeutics(NASDAQ:TRDA) 
Entrada Therapeutics, Inc., a clinical-stage biotechnology company, develops endosomal escape vehicle (EEV) therapeutics for the treatment of multiple neuromuscular diseases. Its EEV platform develops a portfolio of oligonucleotide, antibody, and enzyme-based programs. Its therapeutic candidates, wh...
Share this website to your friends